Literature DB >> 15993873

Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection.

Natàlia Ferré1, Judit Marsillach, Jordi Camps, Anna Rull, Blai Coll, Mònica Tous, Jorge Joven.   

Abstract

BACKGROUND: Hepatitis C virus infection is associated with hepatic free radical formation and enhanced lipid peroxidation and an individual's antioxidant status may play an important role. Paraoxonase-1 is an esterase that degrades oxidised lipids. In the present study, we investigated the genetic association of the most important paraoxonase-1 gene polymorphisms and the susceptibility to HCV-related chronic hepatitis.
METHODS: Paraoxonase-1 polymorphisms at positions -107, 55 and 192 were analysed from the genomic DNA of 186 patients and 386 healthy volunteers, as well as the serum concentration of total peroxides and standard biochemical tests.
RESULTS: Patients with chronic hepatitis had a higher frequency of the RR isoform of the 192 polymorphism than healthy subjects (13% vs. 7%, P<0.05). There were no significant differences with respect to the -107 and 55 polymorphisms. The plasma concentration of peroxides was higher in patients with chronic hepatitis [349.5 (246.2-479.8) vs. 115.4 (95.7-172.3) mumol/L; P<0.001].
CONCLUSIONS: The present study suggests that the paraoxonase-1 192 polymorphism contributes, together with other polymorphisms, to the variations in the host response to HCV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993873     DOI: 10.1016/j.cccn.2005.05.024

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.

Authors:  Alicja E Grzegorzewska; Adrianna Mostowska; Wojciech Warchoł; Paweł P Jagodziński
Journal:  BMC Infect Dis       Date:  2021-08-26       Impact factor: 3.090

2.  Paraoxonase-1 status in patients with hereditary hemochromatosis.

Authors:  Nicola Martinelli; Anabel García-Heredia; Helena Roca; Núria Aranda; Victoria Arija; Bharti Mackness; Michael Mackness; Fabiana Busti; Gerard Aragonès; Juan Pedro-Botet; Federica Pedica; Ivana Cataldo; Judit Marsillach; Jorge Joven; Domenico Girelli; Jordi Camps
Journal:  J Lipid Res       Date:  2013-03-06       Impact factor: 5.922

3.  Measurement of serum paraoxonase-1 activity in the evaluation of liver function.

Authors:  Jordi Camps; Judit Marsillach; Jorge Joven
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

4.  Serum Basal Paraoxonase 1 Activity as an Additional Liver Function Test for the Evaluation of Patients with Chronic Hepatitis.

Authors:  Anand K Pyati; Chandrakanth K Halappa; Sudharani A Pyati; Vinod Wali
Journal:  J Clin Diagn Res       Date:  2015-11-01

Review 5.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.